Search
for
Sort by
Research 421–450 of 1000+
- Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata
- Alopecia Areata: Treatment of Today and Tomorrow
- Alopecia areata: diagnosis and management
- Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse.
- TREATMENT OF ALOPECIA AREATA
- Alopecias cicatriciales
- Management of alopecia areata: Updates and algorithmic approach
- Emerging treatments in alopecia
- Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis
- Loss of Vascular Endothelial Growth Factor in Human Alopecia Hair Follicles
- New and Emerging Therapies for Alopecia Areata
- ‘The psychosocial burden of alopecia areata and androgenetica’: a cross‐sectional multicentre study among dermatological out‐patients in 13 European countries
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Alopecia in the United States: Outpatient utilization and common prescribing patterns
- Serological screening for coeliac disease in vitiligo and alopecia areata
- Alopecia Areata in Korea (1982–1994)
- Treatment-Resistant Alopecia Areata
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Pathomechanisms of immune-mediated alopecia
- Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
- Nail changes in alopecia areata: an update and review
- Plasmacytoid dendritic cells in alopecia areata: missing link?
- Platelet-rich plasma injection is effective and safe for the treatment of alopecia
- Quality of Life in Alopecia Areata: A Sample of Tunisian Patients
- Topical immunotherapy in alopecia areata
- Hypertension and aldosterone levels in women with early-onset androgenetic alopecia
- Treatment of persistent alopecia areata with sulfasalazine
- SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety